195 related articles for article (PubMed ID: 36640924)
1. TEAD Proteins Associate With DNA Repair Proteins to Facilitate Cellular Recovery From DNA Damage.
Calses PC; Pham VC; Guarnaccia AD; Choi M; Verschueren E; Bakker ST; Pham TH; Hinkle T; Liu C; Chang MT; Kljavin N; Bakalarski C; Haley B; Zou J; Yan C; Song X; Lin X; Rowntree R; Ashworth A; Dey A; Lill JR
Mol Cell Proteomics; 2023 Feb; 22(2):100496. PubMed ID: 36640924
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the Hippo Pathway Transcription Factor TEAD.
Lin KC; Park HW; Guan KL
Trends Biochem Sci; 2017 Nov; 42(11):862-872. PubMed ID: 28964625
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors.
Sturbaut M; Bailly F; Coevoet M; Sileo P; Pugniere M; Liberelle M; Magnez R; Thuru X; Chartier-Harlin MC; Melnyk P; Gelin M; Allemand F; Guichou JF; Cotelle P
Eur J Med Chem; 2021 Dec; 226():113835. PubMed ID: 34509860
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic targeting of TEAD transcription factors in cancer.
Pobbati AV; Kumar R; Rubin BP; Hong W
Trends Biochem Sci; 2023 May; 48(5):450-462. PubMed ID: 36709077
[TBL] [Abstract][Full Text] [Related]
5. Structure-Based Design of Y-Shaped Covalent TEAD Inhibitors.
Lu W; Fan M; Ji W; Tse J; You I; Ficarro SB; Tavares I; Che J; Kim AY; Zhu X; Boghossian A; Rees MG; Ronan MM; Roth JA; Hinshaw SM; Nabet B; Corsello SM; Kwiatkowski N; Marto JA; Zhang T; Gray NS
J Med Chem; 2023 Apr; 66(7):4617-4632. PubMed ID: 36946421
[TBL] [Abstract][Full Text] [Related]
6. Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway.
Hori N; Okada K; Takakura Y; Takano H; Yamaguchi N; Yamaguchi N
J Biol Chem; 2020 Jun; 295(26):8798-8807. PubMed ID: 32385107
[TBL] [Abstract][Full Text] [Related]
7. The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis.
Zhou Y; Huang T; Cheng AS; Yu J; Kang W; To KF
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805820
[TBL] [Abstract][Full Text] [Related]
8. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
[TBL] [Abstract][Full Text] [Related]
9. Discovering inhibitors of TEAD palmitate binding pocket through virtual screening and molecular dynamics simulation.
Li Y; Li Y; Ning C; Yue J; Zhang C; He X; Wang Y; Liu Z
Comput Biol Chem; 2022 Jun; 98():107648. PubMed ID: 35288361
[TBL] [Abstract][Full Text] [Related]
10. Emerging roles of TEAD transcription factors and its coactivators in cancers.
Pobbati AV; Hong W
Cancer Biol Ther; 2013 May; 14(5):390-8. PubMed ID: 23380592
[TBL] [Abstract][Full Text] [Related]
11. Identification of Quinolinols as Activators of TEAD-Dependent Transcription.
Pobbati AV; Mejuch T; Chakraborty S; Karatas H; Bharath SR; Guéret SM; Goy PA; Hahne G; Pahl A; Sievers S; Guccione E; Song H; Waldmann H; Hong W
ACS Chem Biol; 2019 Dec; 14(12):2909-2921. PubMed ID: 31742995
[TBL] [Abstract][Full Text] [Related]
12. Targeting Transcriptional Enhanced Associate Domains (TEADs).
Gibault F; Sturbaut M; Bailly F; Melnyk P; Cotelle P
J Med Chem; 2018 Jun; 61(12):5057-5072. PubMed ID: 29251924
[TBL] [Abstract][Full Text] [Related]
13. TEAD family transcription factors in development and disease.
Currey L; Thor S; Piper M
Development; 2021 Jun; 148(12):. PubMed ID: 34128986
[TBL] [Abstract][Full Text] [Related]
14. TEADs mediate nuclear retention of TAZ to promote oncogenic transformation.
Chan SW; Lim CJ; Loo LS; Chong YF; Huang C; Hong W
J Biol Chem; 2009 May; 284(21):14347-58. PubMed ID: 19324876
[TBL] [Abstract][Full Text] [Related]
15. Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice.
Cai WY; Lin LY; Hao H; Zhang SM; Ma F; Hong XX; Zhang H; Liu QF; Ye GD; Sun GB; Liu YJ; Li SN; Xie YY; Cai JC; Li BA
Hepatology; 2017 Apr; 65(4):1206-1221. PubMed ID: 27809333
[TBL] [Abstract][Full Text] [Related]
16. Structure-based derivation and optimization of YAP-like coactivator-derived peptides to selectively target TEAD family transcription factors by hydrocarbon stapling and cyclization.
He B; Wu T; He P; Lv F; Liu H
Chem Biol Drug Des; 2021 Jun; 97(6):1129-1136. PubMed ID: 33283479
[TBL] [Abstract][Full Text] [Related]
17. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X
J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450
[TBL] [Abstract][Full Text] [Related]
18. Palmitoylation of TEAD Transcription Factors Is Required for Their Stability and Function in Hippo Pathway Signaling.
Noland CL; Gierke S; Schnier PD; Murray J; Sandoval WN; Sagolla M; Dey A; Hannoush RN; Fairbrother WJ; Cunningham CN
Structure; 2016 Jan; 24(1):179-186. PubMed ID: 26724994
[TBL] [Abstract][Full Text] [Related]
19. Lysine long-chain fatty acylation regulates the TEAD transcription factor.
Noritsugu K; Suzuki T; Dodo K; Ohgane K; Ichikawa Y; Koike K; Morita S; Umehara T; Ogawa K; Sodeoka M; Dohmae N; Yoshida M; Ito A
Cell Rep; 2023 Apr; 42(4):112388. PubMed ID: 37060904
[TBL] [Abstract][Full Text] [Related]
20. Regulation of TEAD Transcription Factors in Cancer Biology.
Huh HD; Kim DH; Jeong HS; Park HW
Cells; 2019 Jun; 8(6):. PubMed ID: 31212916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
